Real-world effectiveness and persistence of secukinumab in the treatment of patients with psoriatic arthritis

INTRODUCTION: Psoriatic arthritis (PsA) is a complex and heterogeneous inflammatory disease. Secukinumab, a biologic disease-modifying antirheumatic drug (bDMARD), has extensive clinical evidence of efficacy and safety in the treatment of PsA but data in clinical practice are still limited. This stu...

Descripción completa

Detalles Bibliográficos
Autores principales: Alegre-Sancho, Juan José, Núñez-Monje, Victoria, Campos-Fernández, Cristina, Balaguer-Trull, Isabel, Robustillo-Villarino, Montserrat, Aguilar-Zamora, Marta, Garijo-Bufort, Marta, Pedraz-Penalva, Teresa, Peña-González, Carolina, de la Morena, Isabel, Bedoya-Sanchís, Diego, Yankova-Komsalova, Liliya, Conesa-Mateos, Arantxa, Martinez-Cristóbal, Anna, Navarro-Blasco, Francisco Javier, Senabre-Gallego, Jose Miguel, Sivera, Francisca
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10694458/
http://dx.doi.org/10.3389/fmed.2023.1294247

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10694458/
http://dx.doi.org/10.3389/fmed.2023.1294247

Ejemplares similares